Neuphoria Therapeutics In...

5.04
-0.15 (-2.89%)
At close: Apr 25, 2025, 3:59 PM
5.04
0.00%
After-hours: Apr 25, 2025, 04:00 PM EDT

Neuphoria Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2024 Q1 2024 Q2 2023 Q1 2023
Period Ending Dec 31, 2024 Sep 30, 2024 Dec 31, 2023 Sep 30, 2023
662.72K n/a n/a n/a
n/a n/a n/a n/a
662.72K n/a n/a n/a
-17.29M -13.59M -10.02M -5.47M
207.87K 177.25K 141.16K 86.44K
-12.97M -11.03M -10.1M -5.51M
-12.78M -10.83M -10.03M -5.47M
9.19M 6.56M 4.9M 2.38M
8.76M 7.02M 5.12M 3.09M
n/a n/a n/a n/a
17.95M 13.59M 10.02M 5.47M
n/a n/a n/a n/a
n/a n/a n/a n/a
17.95M 13.59M 10.02M 5.47M
-190.16K -201.77K -69.59K -34.79K
1.58M 234.01M 857.26K 124.67M
1.58M 234.01M 857.26K 124.67M
-6.59 -5.36 -5.35 -0.04
-6.59 -5.36 -5.35 -0.04
-16.23M -13M -9.59M -5.3M
-16.89M -13.49M -9.93M -5.47M
663.44K 497.32K 331.6K 165.91K